7-Cyclohexylheptyl-4-O-(a-D-glucopyranosyl)-b-D-glucopyranoside (CAS 349477-49-2)

7-Cyclohexylheptyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside, abbreviated as CHHG-4-O-Glc-Glc, represents an innovative compound. Derived synthetically from cyclohexylheptyl and two glucose molecules, it belongs to the broader class of cyclohexylheptyl glucosides. Extensive research has demonstrated the diverse capabilities of this compound, prompting exploration in various scientific domains. One notable attribute is its ability to modulate the activity of specific proteins. For instance, it exhibits the capacity to influence the behavior of the anti-apoptotic protein Bcl-2, indicating potential implications in cellular processes. Although the precise mechanism of action remains incompletely understood, it is hypothesized that 7-Cyclohexylheptyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside modulates protein activity by binding to them and inducing conformational changes. Additionally, interactions with cellular membrane components, such as G-protein coupled receptors, are theorized to contribute to its effects.